“…One of the answers to the challenges of modern medicine is the development of new biomaterials with increased corrosion resistance and biocompatibility, intended for long-term implants in implantology [ 1 , 2 , 3 ]. The most promising group of biomaterials for such applications is titanium and its single-phase alloys α or β and two-phase alloys α + β, which contain the additions of Al, V, Nb, Ta, Zr, Mo, Si, Sn, Pd, Fe, and Hf and exhibit osseointegrative properties [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 ]. The two-phase Ti–6Al–4V alloy has so far dominated the long-term implant market.…”